SCHEMBL802642

SCHEMBL802642

Cc1cn([C@@H]2O[C@]34CO[Si](C(C)C)(C(C)C)O[Si](C(C)C)(C(C)C)O[C@@H]3C2ON(C)C4)c(=O)nc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15478046 1.00 — —
SCHEMBL802599 0.84 — —
SCHEMBL25968862 0.83 TK1 (0.34) —
SCHEMBL802971 0.78 STING1 (0.39) —
SCHEMBL15478065 0.78 PI4KA (0.39) —
SCHEMBL803169 0.77 NT5E (0.33) —
SCHEMBL803186 0.73 — —
SCHEMBL15478071 0.73 — —
SCHEMBL22518665 0.70 — —
SCHEMBL22518753 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8653254-B2 Process for producing nucleoside TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-02-18 — — US disclosed
US-20120071646-A1 PROCESS FOR PRODUCING NUCLEOSIDE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-22 — — US disclosed
Send feedback